CONFERENCE COMMITTEE REP. NO.83-06

Honolulu, Hawaii

, 2006

RE: H.B. No. 2410

H.D. 1

S.D. 2

C.D. 1

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Honorable Robert Bunda

President of the Senate

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Sir:

Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 2410, H.D. 1, S.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

The purpose of this bill is to amend the Uniform Controlled Substances Act to:

(1) Add the drug Zopiclone (Lunesta) to the list of schedule IV controlled substances;

(2) Clarify that the exception from certain requirements of the Uniform Controlled Substances Act for any over-the-counter sale, transfer, furnishing, or receipt of a drug containing pseudoephedrine or norpseudoephedrine is subject to compliance with the additional restrictions on the sale of over-the-counter pseudoephedrine products imposed by Act 193, Session Laws of Hawaii 2005;

(3) Reduce the amount of pseudoephedrine products that a pharmacy or retailer may dispense, sell, or distribute without a prescription, to 3.6 grams per day without regard to the number of transactions, and no more than nine grams within 30 days;

(4) Require pseudoephedrine products to be sold from an area where the product is delivered directly into the custody of the purchaser;

(5) Require purchasers of pseudoephedrine products to provide identification; and

(6) Require pseudoephedrine purchasers to sign a written log or receipt of the transaction.

Your Committee on Conference has amended this bill by:

(1) Clarifying that the dispensable grams of pseudoephedrine products is 3.6 grams per person each day; and

(2) Making technical, nonsubstantive amendments for clarity and style.

As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 2410, H.D. 1, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 2410, H.D. 1, S.D. 2, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE SENATE

ON THE PART OF THE HOUSE

____________________________

ROSALYN H. BAKER, Chair

____________________________

SYLVIA LUKE, Chair

____________________________

COLLEEN HANABUSA, Co-Chair